Skip to main content
search

Conference: Fierce BIO

Date: January 13 - 14, 2026

Location: Hyatt Regency San Francisco, CA

Certara is proud to partner with Fierce Bio to host an exclusive executive breakfast during Fierce JPM Week in San Francisco. Designed for senior biotech leaders, this invitation-only gathering creates a private forum for candid discussion on how early scientific and strategic decisions can profoundly influence long-term success.

In today’s competitive and capital-conscious biotech environment, the earliest choices, from candidate selection to development strategy, can either accelerate value creation or introduce costly risk. This intimate breakfast session brings together a highly curated group of biotech executives, investors, and industry experts to exchange insights, lessons learned, and practical strategies for derisking early-stage development.

This high-impact conversation will bridge science, strategy, and commercial foresight while enabling meaningful peer-to-peer networking.

Event Details

Date: Tuesday, January 13
Time: 7:30–8:30 AM
Location: Hyatt Regency San Francisco
Event Partner: Fierce Bio

In today’s fast-moving biotech landscape, the earliest decisions can define a company’s future. This private session convenes a prestigious and select group of biotech executives for a candid discussion on how thoughtful planning, rigorous science, and strategic foresight can drive better scientific, clinical, and business outcomes and help derisk early-stage development.

Together, we’ll explore:

  • Lessons learned from early-stage biotech programs that struggled or succeeded
  • How integrated planning and smarter candidate selection drive development success
  • What investors look for when evaluating early assets and strategies to create value
  • How commercial foresight can strengthen decision-making from the very start

Enjoy breakfast and networking while gaining insights into how data-driven, model-informed development strategies can help biotech leaders bring the right drug to the right patient faster and with greater investor confidence.

Speaker panel

Fran Brown, PhD

Global Head, Drug Development Science, Certara

Geoff Fatzinger

Vice President, Regulatory Strategy, Certara

David de Graaf, PhD

Co-Founder, CEO & President, Reverb Therapeutics

Donnie McGrath

CEO, Belenos Biosciences Inc.

Questions about this event?
Please contact: [email protected]